References:
- Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F,
et al. International incidence of childhood cancer, 2001-10: a
population-based registry study. Lancet Oncol. 2017 Jun;18(6):719-731.
- El-Mahallawy HA, El-Din NH, Salah F, El-Arousy M, El-Naga SA.
Epidemiologic profile of symptomatic gastroenteritis in pediatric
oncology patients receiving chemotherapy. Pediatr Blood Cancer; 2004,
42:338–342.
- Davila M, Bresalier RS. Gastrointestinal complications of oncologic
therapy. Nat Clin Pract Gastroenterol Hepatol. 2008;5:682-696.
- Davila ML. Neutropenic enterocolitis. Curr Opin Gastroenterol,
2006;22(1):44-7
- Nesher L, Rolston KV. Neutropenic enterocolitis, a growing concern in
the era of widespread use of aggressive chemotherapy, Clin Infect Dis
2013; 56: 711-717
- Weinberger M, Hollingsworth H, Feuerstein IM, Young NS, Pizzo PA.
Successful surgical management of neutropenic enterocolitis in two
patients with severe aplastic anemia. Case reports and review of the
literature. Arch Intern Med 1993;153(1):107-113
- Tinsa F, Necib N, Guesmi M, Bousnina O, Douira W, Bousetta K, et al.
Fanconi anemia complicated by neutropenic enterocolitis. Tunis Med
2008;86(11):1011-1013
- McCarville MB, Adelman CS, Li C,
Xiong X, Furman WL, Razzouk BI, et al. Typhlitis in childhood cancer.
Cancer, 2005;104(2):380-387
- Rizzatti M, Brandalise SR, de Azevedo AC, Pinheiro VR, Aguiar SS.
Neutropenic enterocolitis in children and young adults with cancer:
prognostic value of clinical and image findings. Pediatr Hematol Oncol
2010;27(6):462-470.
- El-Matary W, Soleimani M, Spady D, Belletrutti M. Typhlitis in
children with malignancy: a single center experience. J Pediatr
Hematol Oncol 2011;33(3):e98-100
- Gomez L, Martino R, Rolston KV. Neutropenic enterocolitis: spectrum of
the disease and comparison of definite and possible cases. Clin Infect
Dis. 1998;27(4):695-9.
- Fike FB, Mortellaro V, Juang D, St Peter SD, Andrews WS, Snyder CL.
Neutropenic colitis in children. J Surg Res. 2011;170(1):73-6.
- Gorschluter M, Mey U, Strehl J, Schmitz V, Rabe C, Pauls K, et al.
Invasive fungal infections in neutropenic enterocolitis: a systematic
analysis of pathogens, incidence, treatment and mortality in adult
patients. BMC Infect Dis; 2006;6:35
- User İR, Akbayram S, Özokutan BH. Clinical Presentation, Prognostic
Factors, and Outcome in Neutropenic Enteropathy of Childhood Leukemia.
J Pediatr Hematol Oncol. 2018;40(3):216-220.
- Gibson RJ, Bowen JM. Biomarkers of regimen-related mucosal injury.
Cancer Treat Rev. 2011;37(6):487-93.
- Lutgens LC, Blijlevens NM, Deutz NE, Donnelly JP, Lambin P, de Pauw
BE. Monitoring myeloablative therapy-induced small bowel toxicity by
serum citrulline concentration: a comparison with sugar permeability
tests. Cancer 2005;103:191–9.
- Wedlake L, McGough C, Hackett C, Thomas K, Blake P, Harrington K, et
al. Can biological markers act as non-invasive, sensitive indicators
of radiation-induced effects in the gastrointestinal mucosa? Aliment
Pharmacol Ther. 2008;27(10):980-7.
- van Vliet MJ, Tissing WJ, Rings EH, Koetse HA, Stellaard F, Kamps WA,
et al. Citrulline as a marker for chemotherapy induced mucosal barrier
injury in pediatric patients. Pediatr Blood Cancer 2009;53:1188–94
- Rotz SJ, Dandoy CE. The microbiome in pediatric oncology. Cancer.
2020;126:3629-3637.
- Galloway-Peña JR, Smith DP, Sahasrabhojane P, Ajami NJ, Wadsworth WD,
Daver NG, et al. The role of the gastrointestinal microbiome in
infectious complications during induction chemotherapy for acute
myeloid leukemia. Cancer. 2016;122:2186-96.
- Jenq RR, Taur Y, Devlin SM, Ponce DM, Goldberg JD, Ahr KF, et al.
Intestinal Blautia Is Associated with Reduced Death from
Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2015
Aug;21(8):1373-83.
- Köhler N, Zeiser R. Intestinal Microbiota Influence Immune Tolerance
Post Allogeneic Hematopoietic Cell Transplantation and Intestinal
GVHD. Front Immunol. 2019; 9:3179
- van Vliet MJ, Harmsen HJ, de Bont ES, Tissing WJ. The role of
intestinal microbiota in the development and severity of
chemotherapy-induced mucositis. PLoS Pathog. 2010;6:e1000879.
- Montassier E, Batard E, Massart S, Gastinne T, Carton T, Caillon J, et
al. 16S rRNA gene pyrosequencing reveals shift in patient faecal
microbiota during high-dose chemotherapy as conditioning regimen for
bone marrow transplantation. Microb Ecol. 2014;67:690-9.
- Zwielehner J, Lassl C, Hippe B, Pointner A, Switzeny OJ, Remely M, et
al. Changes in human faecal microbiota due to chemotherapy analyzed by
TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting. PLoS One.
2011;6:e28654.
- Chua LL, Rajasuriar R, Lim YAL, Woo YL, Loke P, Ariffin H. Temporal
changes in gut microbiota profile in children with acute lymphoblastic
leukemia prior to commencement-, during-, and post-cessation of
chemotherapy. BMC Cancer. 2020: 24;20:151.
- van Vliet MJ, Tissing WJ, Dun CA, Meessen NE, Kamps WA, de Bont ES, et
al. Chemotherapy treatment in pediatric patients with acute myeloid
leukemia receiving antimicrobial prophylaxis leads to a relative
increase of colonization with potentially pathogenic bacteria in the
gut. Clin Infect Dis. 2009;49:262-70.
- Stringer AM, Al-Dasooqi N, Bowen JM, Tan TH, Radzuan M, Logan RM, et
al. Biomarkers of chemotherapy-induced diarrhoea: a clinical study of
intestinal microbiome alterations, inflammation and circulating matrix
metalloproteinases. Support Care Cancer. 2013;21:1843-52.
- Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et
al; Acute Pancreatitis Classification Working Group. Classification of
acute pancreatitis-2012: revision of the Atlanta classification and
definitions by international consensus. Gut. 2013;62:102-11.
- Moran H, Yaniv I, Ashkenazi S, Schwartz M, Fisher S, Levy I. Risk
factors for typhlitis in pediatric patients with cancer. J Pediatr
Hematol Oncol 2009;31:630-634.
- Altinel E, Yarali N, Isik P, Bay A, Kara A, Tunc B. Typhlitis in acute
childhood leukemia. Med Princ Pract 2012;21:36-39.
- Mullassery D, Bader A, Battersby AJ, Mohammad Z, Jones EL, Parmar C,
et al. Diagnosis, incidence, and outcomes of suspected typhlitis in
oncology patients–experience in a tertiary pediatric surgical
center in the United Kingdom. J Pediatr Surg 2009;44:381-385.
- Sundell N, Boström H, Edenholm M, Abrahamsson J. Management of
neutropenic enterocolitis in children with cancer. Acta Paediatr.
2012;101:308-12.
- Kaito S, Sekiya N, Najima Y, Sano N, Horiguchi S, Kakihana K, et al.
Fatal Neutropenic Enterocolitis Caused by Stenotrophomonas
maltophilia: A Rare and Underrecognized Entity. Intern Med. 2018 Dec
15;57(24):3667-3671.
- Cartoni C, Dragoni F, Micozzi A, Pescarmona E, Mecarocci S, Chirletti
P, et al. Neutropenic enterocolitis in patients with acute leukemia:
prognostic significance of bowel wall thickening detected by
ultrasonography. J Clin Oncol 2001;19(3):756-761
- Rajagopala SV, Yooseph S, Harkins DM, Moncera KJ, Zabokrtsky KB,
Torralba MG, et al. Gastrointestinal microbial populations can
distinguish pediatric and adolescent Acute Lymphoblastic Leukemia
(ALL) at the time of disease diagnosis. BMC Genomics. 2016; 17:635.
- Huang Y, Yang W, Liu H, Duan J,
Zhang Y, Liu M, et al. Effect of high-dose methotrexate chemotherapy
on intestinal Bifidobacteria, Lactobacillus and Escherichia coli in
children with acute lymphoblastic leukemia. Exp Biol Med (Maywood).
2012 Mar;237(3):305-11.
- Bamola VD, Ghosh A, Kapardar RK, Lal B, Cheema S, Sarma P, et al. Gut
microbial diversity in health and disease: experience of healthy
Indian subjects, and colon carcinoma and inflammatory bowel disease
patients. Microb Ecol Health Dis. 2017 May 19;28(1):1322447.